drugset / Trial / NCT05167552
Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells
Phase 1/2
Unknown
60 enrolled
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
The Republican Center for Research and Practice in Otolaryngology · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Treatment of patients with allergic rhinitis and chronic polypous rhinosinusitis with olfactory mucosa-derived mesenchymal stem cells
Timeline
- Start
- 2022-03-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olfactory mucosa-derived mesenchymal stem cells | Cell therapy | — | — |